Chemical Structure : Lebrikizumab
CAS No.: 953400-68-5
货号: PC-Ab1053Not For Human Use, Lab Use Only.
Lebrikizumab is a novel high-affinity monoclonal antibody targeting IL-13 that selectively blocks the IL-13 receptor α1 (IL-13Rα1) and IL-4Rα heterodimer signaling complex. Lebrikizumab shows high bioavailability, a long half-life and blocks IL-13 signaling..
| 规格 | 价格 | 库存 | 数量 | 
|---|---|---|---|
| 1 mg | ¥3580 | In stock | |
| 5 mg | ¥7580 | In stock | |
| 10 mg | ¥12800 | In stock | |
| 100 mg | Get quote | 
大包装,大折扣!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
Lebrikizumab is a novel high-affinity monoclonal antibody targeting IL-13 that selectively blocks the IL-13 receptor α1 (IL-13Rα1) and IL-4Rα heterodimer signaling complex. Lebrikizumab shows high bioavailability, a long half-life and blocks IL-13 signaling.
| 分子量 | ||
| 分子式 | Human IgG4P-Kappa | |
| 外观性状 | Solid | |
| 储存条件 | 
                            
  | 
                        
                            
  | 
                    
| Solubility | 
                             PBS, pH 7.0 Contains no stabilizers or preservatives  | 
                    |
| Chemical Name/SMILES | 
                             Lebrikizumab; DRM-06; LY-3650150; MILR1444A; MILR1444Ab; RG-3637; RO-5490255; TNX 650; 953400-68-5; Interleukin 13 signaling; IL-13 antibody  | 
                    |
1. 1, Guttman-Yassky E, et al. JAMA Dermatol. 2020 Apr 1;156(4):411-420. 2, Simpson EL, et al. J Am Acad Dermatol. 2018 May;78(5):863-871.e11. 3, Loh TY, et al. J Asthma Allergy. 2020 Feb 11;13:109-114. 4, Corren J, et al. N Engl J Med. 2011 Sep 22;365(12):1088-98.
备案号:沪ICP备16042516号-1 Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright